Evoke Pharma Inc (EVOK)
4.33
-0.17
(-3.78%)
USD |
NASDAQ |
Nov 22, 16:00
4.22
-0.11
(-2.54%)
After-Hours: 20:00
Evoke Pharma Free Cash Flow: -5.325M for Sept. 30, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| September 30, 2024 | -5.325M |
| June 30, 2024 | -5.548M |
| March 31, 2024 | -5.934M |
| December 31, 2023 | -4.985M |
| September 30, 2023 | -6.385M |
| June 30, 2023 | -6.444M |
| March 31, 2023 | -6.612M |
| December 31, 2022 | -6.596M |
| September 30, 2022 | -6.087M |
| June 30, 2022 | -10.88M |
| March 31, 2022 | -11.01M |
| December 31, 2021 | -12.35M |
| September 30, 2021 | -12.07M |
| June 30, 2021 | -7.986M |
| March 31, 2021 | -8.031M |
| December 31, 2020 | -6.63M |
| September 30, 2020 | -6.066M |
| June 30, 2020 | -5.315M |
| March 31, 2020 | -5.387M |
| December 31, 2019 | -5.762M |
| September 30, 2019 | -5.863M |
| June 30, 2019 | -5.954M |
| March 31, 2019 | -6.088M |
| December 31, 2018 | -6.979M |
| Date | Value |
|---|---|
| September 30, 2018 | -8.463M |
| June 30, 2018 | -9.514M |
| March 31, 2018 | -9.848M |
| December 31, 2017 | -8.717M |
| September 30, 2017 | -7.353M |
| June 30, 2017 | -7.571M |
| March 31, 2017 | -7.704M |
| December 31, 2016 | -8.708M |
| September 30, 2016 | -9.791M |
| June 30, 2016 | -9.877M |
| March 31, 2016 | -10.19M |
| December 31, 2015 | -10.50M |
| September 30, 2015 | -10.56M |
| June 30, 2015 | -11.97M |
| March 31, 2015 | -12.50M |
| December 31, 2014 | -11.50M |
| September 30, 2014 | -10.87M |
| June 30, 2014 | -7.232M |
| March 31, 2014 | -4.594M |
| December 31, 2013 | -3.040M |
| September 30, 2013 | -1.804M |
| June 30, 2013 | -1.831M |
| March 31, 2013 | -1.749M |
| December 31, 2012 | -1.750M |
Free Cash Flow Range, Past 5 Years
-12.35M
Minimum
Dec 2021
-4.985M
Maximum
Dec 2023
-7.270M
Average
-6.415M
Median
Free Cash Flow Benchmarks
| Eli Lilly and Co | -2.275B |
| MEI Pharma Inc | -43.43M |
| Revance Therapeutics Inc | -194.91M |
| NovaBay Pharmaceuticals Inc | -4.812M |
| Palatin Technologies Inc | -32.57M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -0.8187M |
| Cash from Financing (Quarterly) | 2.980M |
| Free Cash Flow Per Share (Quarterly) | -0.5848 |
| Free Cash Flow to Equity (Quarterly) | -0.8187M |
| Free Cash Flow Yield | -129.5% |